{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:21:49Z","timestamp":1791555709545,"version":"4.3.4"},"reference-count":102,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>Diffuse intrinsic pontine glioma (DIPG) is a fatal childhood brainstem malignancy. Despite advances in understanding of the molecular underpinnings of the tumor in the past decade, the dismal prognosis of DIPG has thus far remained unchanged. This review seeks to highlight promising therapeutic targets within three arenas: DIPG cell-intrinsic vulnerabilities, immunotherapeutic approaches to tumor clearance, and microenvironmental dependencies that promote tumor growth.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Promising therapeutic strategies from recent studies include epigenetic modifying agents such as histone deacetylase inhibitors, bromodomain and extra-terminal motif (BET) protein inhibitors, and CDK7 inhibitors. Tumor-specific immunotherapies are emerging. Key interactions between DIPG and normal brain cells are coming to light, and targeting critical microenvironmental mechanisms driving DIPG growth in the developing childhood brain represents a new direction for therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Several DIPG treatment strategies are being evaluated in early clinical trials. Ultimately, we suspect that a multifaceted therapeutic approach utilizing cell-intrinsic, microenvironmental, and immunotherapeutic targets will be necessary for eradicating DIPG.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cco.0000000000000577","type":"journal-article","created":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T10:52:26Z","timestamp":1567075946000},"page":"522-530","source":"Crossref","is-referenced-by-count":80,"title":["Diffuse intrinsic pontine glioma: molecular landscape and emerging therapeutic targets"],"prefix":"10.1097","volume":"31","author":[{"given":"Razina","family":"Aziz-Bose","sequence":"first","affiliation":[{"name":"Department of Neurology and Neurological Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Monje","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurological Sciences"},{"name":"Stanford Institute for Stem Cell Biology and Regenerative Medicine"},{"name":"Stanford Cancer Institute"},{"name":"Department of Pediatrics"},{"name":"Department of Psychiatry and Behavioral Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230901","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/neuonc\/nox107","article-title":"Contemporary survival endpoints: an International Diffuse Intrinsic Pontine Glioma Registry study","volume":"19","author":"Cooney","year":"2017","journal-title":"Neuro Oncol"},{"key":"R2-20230901","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2017.75.9308","article-title":"Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of diffuse intrinsic pontine glioma (DIPG): a collaborative report from the International and European Society for Pediatric Oncology DIPG Registries","volume":"36","author":"Hoffman","year":"2018","journal-title":"J Clin Oncol"},{"key":"R3-20230901","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","article-title":"Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma","volume":"32","author":"Mackay","year":"2017","journal-title":"Cancer Cell"},{"key":"R4-20230901","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00401-014-1307-x","article-title":"Subventricular spread of diffuse intrinsic pontine glioma","volume":"128","author":"Caretti","year":"2014","journal-title":"Acta Neuropathol"},{"key":"R5-20230901","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.cell.2017.07.016","article-title":"Neural precursor-derived pleiotrophin mediates subventricular zone invasion by glioma","volume":"170","author":"Qin","year":"2017","journal-title":"Cell"},{"key":"R6-20230901","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/neuonc\/nox021","article-title":"Diffuse intrinsic pontine gliomas-current management and new biologic insights. Is there a glimmer of hope?","volume":"19","author":"Cohen","year":"2017","journal-title":"Neuro Oncol"},{"key":"R7-20230901","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijrobp.2009.04.031","article-title":"Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma","volume":"77","author":"Jalali","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R8-20230901","first-page":"e55360","article-title":"A protocol for rapid postmortem cell culture of diffuse intrinsic pontine glioma (DIPG)","volume":"121","author":"Lin","year":"2017","journal-title":"J Vis Exp"},{"key":"R9-20230901","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","article-title":"K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas","volume":"124","author":"Khuong-Quang","year":"2012","journal-title":"Acta Neuropathol"},{"key":"R10-20230901","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10833","article-title":"Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma","volume":"482","author":"Schwartzentruber","year":"2012","journal-title":"Nature"},{"key":"R11-20230901","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/ng.1102","article-title":"Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and nonbrainstem glioblastomas","volume":"44","author":"Wu","year":"2012","journal-title":"Nat Genet"},{"key":"R12-20230901","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"R13-20230901","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ccr.2013.10.006","article-title":"Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas","volume":"24","author":"Bender","year":"2013","journal-title":"Cancer Cell"},{"key":"R14-20230901","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1126\/science.1232245","article-title":"Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma","volume":"340","author":"Lewis","year":"2013","journal-title":"Science"},{"key":"R15-20230901","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/bpa.12042","article-title":"Evaluation of histone 3 lysine 27 trimethylation (H3K27me3) and enhancer of Zest 2 (EZH2) in pediatric glial and glioneuronal tumors shows decreased H3K27me3 in H3F3A K27M mutant glioblastomas","volume":"23","author":"Venneti","year":"2013","journal-title":"Brain Pathol Zurich Switz"},{"key":"R16-20230901","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1101\/gad.217778.113","article-title":"The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression","volume":"27","author":"Chan","year":"2013","journal-title":"Genes Dev"},{"key":"R17-20230901","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1126\/science.1253799","article-title":"Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation","volume":"346","author":"Funato","year":"2014","journal-title":"Science"},{"key":"R18-20230901","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ng.2925","article-title":"Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma","volume":"46","author":"Taylor","year":"2014","journal-title":"Nat Genet"},{"key":"R19-20230901","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nm.3855","article-title":"Functionally defined therapeutic targets in diffuse intrinsic pontine glioma","volume":"21","author":"Grasso","year":"2015","journal-title":"Nat Med"},{"key":"R20-20230901","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ccell.2017.03.011","article-title":"Transcriptional dependencies in diffuse intrinsic pontine glioma","volume":"31","author":"Nagaraja","year":"2017","journal-title":"Cancer Cell"},{"key":"R21-20230901","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1073\/pnas.1101657108","article-title":"Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma","volume":"108","author":"Monje","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R22-20230901","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/PAS.0b013e318294e817","article-title":"Morphologic characteristics and immunohistochemical profile of diffuse intrinsic pontine gliomas","volume":"37","author":"Ballester","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R23-20230901","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/cne.23690","article-title":"Postnatal growth of the human pons: a morphometric and immunohistochemical analysis: human postnatal pons development","volume":"523","author":"Tate","year":"2015","journal-title":"J Comp Neurol"},{"key":"R24-20230901","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1126\/science.aao4750","article-title":"Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq","volume":"360","author":"Filbin","year":"2018","journal-title":"Science"},{"key":"R25-20230901","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ccell.2018.11.015","article-title":"Histone H3.3 K27M accelerates spontaneous brainstem glioma and drives restricted changes in bivalent gene expression","volume":"35","author":"Larson","year":"2019","journal-title":"Cancer Cell"},{"key":"R26-20230901","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nm.4293","article-title":"EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas","volume":"23","author":"Mohammad","year":"2017","journal-title":"Nat Med"},{"key":"R27-20230901","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s12264-018-00329-6","article-title":"Diffuse intrinsic pontine gliomas exhibit cell biological and molecular signatures of fetal hindbrain-derived neural progenitor cells","volume":"35","author":"Sun","year":"2019","journal-title":"Neurosci Bull"},{"key":"R28-20230901","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00401-015-1478-0","article-title":"Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes","volume":"130","author":"Castel","year":"2015","journal-title":"Acta Neuropathol"},{"key":"R29-20230901","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s40478-018-0614-1","article-title":"Transcriptomic and epigenetic profiling of \u2018diffuse midline gliomas, H3 K27M-mutant\u2019 discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location","volume":"6","author":"Castel","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"R30-20230901","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ccr.2012.08.024","article-title":"Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma","volume":"22","author":"Sturm","year":"2012","journal-title":"Cancer Cell"},{"key":"R31-20230901","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrc3811","article-title":"Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma","volume":"14","author":"Jones","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"R32-20230901","first-page":"153","article-title":"Pediatric high-grade glioma: biologically and clinically in need of new thinking","volume":"19","author":"Jones","year":"2017","journal-title":"Neuro Oncol"},{"key":"R33-20230901","doi-asserted-by":"crossref","first-page":"11185","DOI":"10.1038\/ncomms11185","article-title":"Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma","volume":"7","author":"Nikbakht","year":"2016","journal-title":"Nat Commun"},{"key":"R34-20230901","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/s41591-018-0086-7","article-title":"Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells","volume":"24","author":"Vinci","year":"2018","journal-title":"Nat Med"},{"key":"R35-20230901","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ng.2936","article-title":"Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations","volume":"46","author":"Buczkowicz","year":"2014","journal-title":"Nat Genet"},{"key":"R36-20230901","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nm.4296","article-title":"Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas","volume":"23","author":"Piunti","year":"2017","journal-title":"Nat Med"},{"key":"R37-20230901","doi-asserted-by":"crossref","first-page":"eaau5935","DOI":"10.1126\/sciadv.aau5935","article-title":"Multiple modes of PRC2 inhibition elicit global chromatin alterations in H3K27M pediatric glioma","volume":"4","author":"Stafford","year":"2018","journal-title":"Sci Adv"},{"key":"R38-20230901","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1038\/s41467-018-04455-7","article-title":"Live-cell single-molecule dynamics of PcG proteins imposed by the DIPG H3.3K27M mutation","volume":"9","author":"Tatavosian","year":"2018","journal-title":"Nat Commun"},{"key":"R39-20230901","doi-asserted-by":"crossref","first-page":"e36696","DOI":"10.7554\/eLife.36696","article-title":"H3.3K27M mutant proteins reprogram epigenome by sequestering the PRC2 complex to poised enhancers","volume":"7","author":"Fang","year":"2018","journal-title":"eLife"},{"key":"R40-20230901","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/s41467-019-09140-x","article-title":"H3K27M induces defective chromatin spread of PRC2-mediated repressive H3K27me2\/me3 and is essential for glioma tumorigenesis","volume":"10","author":"Harutyunyan","year":"2019","journal-title":"Nat Commun"},{"key":"R41-20230901","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1158\/1078-0432.CCR-12-0560","article-title":"Inhibition of histone deacetylation potentiates the evolution of acquired temozolomide resistance linked to MGMT upregulation in glioblastoma xenografts","volume":"18","author":"Kitange","year":"2012","journal-title":"Clin Cancer Res"},{"key":"R42-20230901","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00401-011-0866-3","article-title":"A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat","volume":"122","author":"Milde","year":"2011","journal-title":"Acta Neuropathol"},{"key":"R43-20230901","doi-asserted-by":"crossref","first-page":"13498","DOI":"10.1021\/ja5060934","article-title":"Strategy for \u2018detoxification\u2019 of a cancer-derived histone mutant based on mapping its interaction with the methyltransferase PRC2","volume":"136","author":"Brown","year":"2014","journal-title":"J Am Chem Soc"},{"key":"R44-20230901","doi-asserted-by":"crossref","first-page":"e0169485","DOI":"10.1371\/journal.pone.0169485","article-title":"Pre-clinical study of panobinostat in xenograft and genetically engineered murine diffuse intrinsic pontine glioma models","volume":"12","author":"Hennika","year":"2017","journal-title":"PLoS One"},{"key":"R45-20230901","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ccell.2019.04.004","article-title":"Pervasive H3K27 acetylation leads to ERV expression and a therapeutic vulnerability in H3K27M gliomas","volume":"35","author":"Krug","year":"2019","journal-title":"Cancer Cell"},{"key":"R46-20230901","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3171\/2018.2.PEDS17663","article-title":"The distribution, clearance, and brainstem toxicity of panobinostat administered by convection-enhanced delivery","volume":"22","author":"Singleton","year":"2018","journal-title":"J Neurosurg Pediatr"},{"key":"R47-20230901","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S1470-2045(18)30322-X","article-title":"Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial","volume":"19","author":"Souweidane","year":"2018","journal-title":"Lancet Oncol"},{"key":"R48-20230901","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2174\/1570159X14666160614093615","article-title":"Convection-enhanced delivery for diffuse intrinsic pontine glioma treatment","volume":"15","author":"Zhou","year":"2017","journal-title":"Curr Neuropharmacol"},{"key":"R49-20230901","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1097\/MPH.0000000000000806","article-title":"Concomitant use of panobinostat and reirradiation in progressive DIPG: report of 2 cases","volume":"39","author":"Wang","year":"2017","journal-title":"J Pediatr Hematol Oncol"},{"key":"R50-20230901","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/nm.3716","article-title":"Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma","volume":"20","author":"Hashizume","year":"2014","journal-title":"Nat Med"},{"key":"R51-20230901","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1158\/1541-7786.MCR-16-0389","article-title":"Histone H3.3K27M represses p16 to accelerate gliomagenesis in a murine model of DIPG","volume":"15","author":"Cordero","year":"2017","journal-title":"Mol Cancer Res"},{"key":"R52-20230901","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-0042-105292","article-title":"No significant cytotoxic effect of the EZH2 inhibitor tazemetostat (EPZ-6438) on pediatric glioma cells with wildtype histone 3 or mutated histone 3.3","volume":"228","author":"Wiese","year":"2016","journal-title":"Klin Padiatr"},{"key":"R53-20230901","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13578-017-0184-0","article-title":"Combination of EZH2 inhibitor and BET inhibitor for treatment of diffuse intrinsic pontine glioma","volume":"7","author":"Zhang","year":"2017","journal-title":"Cell Biosci"},{"key":"R54-20230901","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neo.2015.12.002","article-title":"A novel mouse model of diffuse intrinsic pontine glioma initiated in Pax3-expressing cells","volume":"18","author":"Misuraca","year":"2016","journal-title":"Neoplasia"},{"key":"R55-20230901","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ccell.2017.09.014","article-title":"H3.3K27M cooperates with Trp53 loss and PDGFRA gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas","volume":"32","author":"Pathania","year":"2017","journal-title":"Cancer Cell"},{"key":"R56-20230901","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ccell.2018.12.005","article-title":"Tails of a super histone","volume":"35","author":"Sin-Chan","year":"2019","journal-title":"Cancer Cell"},{"key":"R57-20230901","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/ng.2950","article-title":"Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma","volume":"46","author":"Fontebasso","year":"2014","journal-title":"Nat Genet"},{"key":"R58-20230901","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/s41467-019-08823-9","article-title":"ACVR1 R206H cooperates with H3.1K27M in promoting diffuse intrinsic pontine glioma pathogenesis","volume":"10","author":"Hoeman","year":"2019","journal-title":"Nat Commun"},{"key":"R59-20230901","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fonc.2018.00191","article-title":"CDK4\/6 and PDGFRA signaling as therapeutic targets in diffuse intrinsic pontine glioma","volume":"8","author":"Hoeman","year":"2018","journal-title":"Front Oncol"},{"key":"R60-20230901","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41698-017-0033-y","article-title":"Multifocal sequencing of a diffuse intrinsic pontine glioma establishes PTEN loss as an early event","volume":"1","author":"Koschmann","year":"2017","journal-title":"NPJ Precis Oncol"},{"key":"R61-20230901","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/neuonc\/nor190","article-title":"Genomic aberrations in pediatric diffuse intrinsic pontine gliomas","volume":"14","author":"Warren","year":"2012","journal-title":"Neuro Oncol"},{"key":"R62-20230901","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1200\/JCO.2009.25.5463","article-title":"Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets","volume":"28","author":"Zarghooni","year":"2010","journal-title":"J Clin Oncol"},{"key":"R63-20230901","first-page":"455","article-title":"Preclinical analysis of MTOR complex 1\/2 inhibition in diffuse intrinsic pontine glioma","volume":"39","author":"Flannery","year":"2018","journal-title":"Oncol Rep"},{"key":"R64-20230901","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.canlet.2017.04.019","article-title":"The dual mTOR kinase inhibitor TAK228 inhibits tumorigenicity and enhances radiosensitization in diffuse intrinsic pontine glioma","volume":"400","author":"Miyahara","year":"2017","journal-title":"Cancer Lett"},{"key":"R65-20230901","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.2147\/CMAR.S167095","article-title":"Combined use of CDK4\/6 and mTOR inhibitors induce synergistic growth arrest of diffuse intrinsic pontine glioma cells via mutual downregulation of mTORC1 activity","volume":"10","author":"Asby","year":"2018","journal-title":"Cancer Manag Res"},{"key":"R66-20230901","doi-asserted-by":"crossref","first-page":"7541","DOI":"10.18632\/oncotarget.24045","article-title":"Dual targeting of mitochondrial function and mTOR pathway as a therapeutic strategy for diffuse intrinsic pontine glioma","volume":"9","author":"Tsoli","year":"2018","journal-title":"Oncotarget"},{"key":"R67-20230901","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/neuonc\/noz053","article-title":"Inhibition of mutant PPM1D enhances DNA damage response and growth suppressive effects of ionizing radiation in diffuse intrinsic pontine glioma","volume":"21","author":"Akamandisa","year":"2019","journal-title":"Neuro Oncol"},{"key":"R68-20230901","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s42003-019-0420-8","article-title":"ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma","volume":"2","author":"Carvalho","year":"2019","journal-title":"Commun Biol"},{"key":"R69-20230901","doi-asserted-by":"crossref","first-page":"e1328340","DOI":"10.1080\/2162402X.2017.1328340","article-title":"K27M-mutant histone-3 as a novel target for glioma immunotherapy","volume":"6","author":"Ochs","year":"2017","journal-title":"Oncoimmunology"},{"key":"R70-20230901","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fonc.2018.00127","article-title":"Immune response generated with the administration of autologous dendritic cells pulsed with an allogenic tumoral cell-lines lysate in patients with newly diagnosed diffuse intrinsic pontine glioma","volume":"8","author":"Benitez-Ribas","year":"2018","journal-title":"Front Oncol"},{"key":"R71-20230901","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/neuonc\/noy145","article-title":"Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy","volume":"21","author":"Lieberman","year":"2019","journal-title":"Neuro Oncol"},{"key":"R72-20230901","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s40478-018-0553-x","article-title":"Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma","volume":"6","author":"Lin","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"R73-20230901","doi-asserted-by":"crossref","first-page":"224ra25","DOI":"10.1126\/scitranslmed.3008226","article-title":"Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia","volume":"6","author":"Davila","year":"2014","journal-title":"Sci Transl Med"},{"key":"R74-20230901","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N Engl J Med"},{"key":"R75-20230901","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1056\/NEJMoa1610497","article-title":"Regression of glioblastoma after chimeric antigen receptor T-cell therapy","volume":"375","author":"Brown","year":"2016","journal-title":"N Engl J Med"},{"key":"R76-20230901","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1084\/jem.20171046","article-title":"Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy","volume":"215","author":"Chheda","year":"2018","journal-title":"J Exp Med"},{"key":"R77-20230901","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41591-018-0006-x","article-title":"Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas","volume":"24","author":"Mount","year":"2018","journal-title":"Nat Med"},{"key":"R78-20230901","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nm.3838","article-title":"4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors","volume":"21","author":"Long","year":"2015","journal-title":"Nat Med"},{"key":"R79-20230901","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.ymthe.2017.05.012","article-title":"CAR T cells administered in combination with lymphodepletion and PD-1 inhibition to patients with neuroblastoma","volume":"25","author":"Heczey","year":"2017","journal-title":"Mol Ther J Am Soc Gene Ther"},{"key":"R80-20230901","doi-asserted-by":"crossref","first-page":"6050","DOI":"10.1182\/blood-2011-05-354449","article-title":"Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma","volume":"118","author":"Louis","year":"2011","journal-title":"Blood"},{"key":"R81-20230901","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/nm.1882","article-title":"Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma","volume":"14","author":"Pule","year":"2008","journal-title":"Nat Med"},{"key":"R82-20230901","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s11060-018-2991-5","article-title":"Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience","volume":"140","author":"Kline","year":"2018","journal-title":"J Neurooncol"},{"key":"R83-20230901","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11060-017-2643-1","article-title":"Preliminary results of immune modulating antibody MDV9300 (pidilizumab) treatment in children with diffuse intrinsic pontine glioma","volume":"136","author":"Fried","year":"2018","journal-title":"J Neurooncol"},{"key":"R84-20230901","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.neuroimage.2011.11.094","article-title":"Diffusion tensor imaging of white matter tract evolution over the lifespan","volume":"60","author":"Lebel","year":"2012","journal-title":"NeuroImage"},{"key":"R85-20230901","article-title":"The myelogenetic cycles of regional maturation of the brain","author":"Yakovlev","year":"1967","journal-title":"Regional development of the brain in early life"},{"key":"R86-20230901","doi-asserted-by":"crossref","first-page":"1252304","DOI":"10.1126\/science.1252304","article-title":"Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain","volume":"344","author":"Gibson","year":"2014","journal-title":"Science"},{"key":"R87-20230901","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41593-018-0121-5","article-title":"Myelin remodeling through experience-dependent oligodendrogenesis in the adult somatosensory cortex","volume":"21","author":"Hughes","year":"2018","journal-title":"Nat Neurosci"},{"key":"R88-20230901","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1126\/science.1254960","article-title":"Motor skill learning requires active central myelination","volume":"346","author":"McKenzie","year":"2014","journal-title":"Science"},{"key":"R89-20230901","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41467-017-02719-2","article-title":"Pharmacogenetic stimulation of neuronal activity increases myelination in an axon-specific manner","volume":"9","author":"Mitew","year":"2018","journal-title":"Nat Commun"},{"key":"R90-20230901","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.neuron.2019.04.032","article-title":"Loss of adaptive myelination contributes to methotrexate chemotherapy-related cognitive impairment","volume":"103","author":"Geraghty","year":"2019","journal-title":"Neuron"},{"key":"R91-20230901","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.cell.2015.04.012","article-title":"Neuronal activity promotes glioma growth through neuroligin-3 secretion","volume":"161","author":"Venkatesh","year":"2015","journal-title":"Cell"},{"key":"R92-20230901","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nature24014","article-title":"Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma","volume":"549","author":"Venkatesh","year":"2017","journal-title":"Nature"},{"key":"R93-20230901","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrn3765","article-title":"A neurocentric perspective on glioma invasion","volume":"15","author":"Cuddapah","year":"2014","journal-title":"Nat Rev Neurosci"},{"key":"R94-20230901","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1460-9568.1998.00036.x","article-title":"Functional GABA(A) receptors on human glioma cells","volume":"10","author":"Labrakakis","year":"1998","journal-title":"Eur J Neurosci"},{"key":"R95-20230901","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1046\/j.0953-816x.2001.01764.x","article-title":"GABA(A)-receptor expression in glioma cells is triggered by contact with neuronal cells","volume":"14","author":"Synowitz","year":"2001","journal-title":"Eur J Neurosci"},{"key":"R96-20230901","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ccell.2016.05.002","article-title":"Inhibition of dopamine receptor D4 impedes autophagic flux, proliferation, and survival of glioblastoma stem cells","volume":"29","author":"Dolma","year":"2016","journal-title":"Cancer Cell"},{"key":"R97-20230901","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1016\/j.wneu.2019.04.180","article-title":"Synergistic suppression of glioblastoma cell growth by combined application of temozolomide and dopamine D2 receptor antagonists","volume":"128","author":"Liu","year":"2019","journal-title":"World Neurosurg"},{"key":"R98-20230901","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3171\/2019.2.PEDS18480","article-title":"First clinical experience with DRD2\/3 antagonist ONC201 in H3 K27M-mutant pediatric diffuse intrinsic pontine glioma: a case report","volume":"23","author":"Hall","year":"2019","journal-title":"J Neurosurg Pediatr"},{"key":"R99-20230901","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nm.2453","article-title":"Glutamate release by primary brain tumors induces epileptic activity","volume":"17","author":"Buckingham","year":"2011","journal-title":"Nat Med"},{"key":"R100-20230901","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/j.1528-1167.2012.03557.x","article-title":"Human glioma cells induce hyperexcitability in cortical networks","volume":"53","author":"Campbell","year":"2012","journal-title":"Epilepsia"},{"key":"R101-20230901","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nm746","article-title":"Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells","volume":"8","author":"Ishiuchi","year":"2002","journal-title":"Nat Med"},{"key":"R102-20230901","doi-asserted-by":"crossref","first-page":"7987","DOI":"10.1523\/JNEUROSCI.2180-07.2007","article-title":"Ca2+-permeable AMPA receptors regulate growth of human glioblastoma via Akt activation","volume":"27","author":"Ishiuchi","year":"2007","journal-title":"J Neurosci"}],"container-title":["Current Opinion in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCO.0000000000000577","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T03:04:31Z","timestamp":1693537471000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCO.0000000000000577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":102,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/cco.0000000000000577","relation":{},"ISSN":["1040-8746","1531-703X"],"issn-type":[{"value":"1040-8746","type":"print"},{"value":"1531-703X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}